Jinekolojik Onkolojide İndosiyanin Yeşili (ICG) Kullanımı
Özet
İndosiyanin yeşili (ICG), jinekolojik onkoloji cerrahisinde endometrium, serviks ve vulva kanserlerinin evrelemesi için sentinel lenf nodu haritalamasında kullanılan onaylı bir floresan görüntüleme ajanıdır. Yakın kızılötesi floresan teknolojisi sayesinde canlı dokularda lenfatik kanalların ve ilk metastaz odaklarının yüksek doğrulukla tespit edilmesini sağlayarak, sistematik lenfadenektominin neden olabileceği lenfödem gibi komplikasyonların azaltılmasına yardımcı olur. Özellikle erken evre vakalarda cerrahi sınırların belirlenmesi ve adjuvan tedavi kararlarının verilmesinde kritik bir rol oynayan bu yöntem, modern jinekolojik onkoloji kılavuzları tarafından da desteklenmektedir.
Indocyanine green (ICG) is an approved fluorescent imaging agent used for sentinel lymph node mapping in the surgical staging of endometrial, cervical, and vulvar cancers in gynecologic oncology. Utilizing near-infrared fluorescence technology, it enables high-accuracy detection of lymphatic channels and initial metastatic sites, helping to reduce complications such as lymphedema associated with systematic lymphadenectomy. This method plays a critical role in determining surgical margins and adjuvant therapy decisions, particularly in early-stage cases, and is supported by modern gynecologic oncology guidelines.
Referanslar
Zhu B, Sevick-Muraca EM. A review of performance of near-infrared fluorescence imaging devices used in clinical studies. Br J Radiol 2015; 88:20140547.
Holloway RW, Abu-Rustum NR, Backes FJ,et al. Sentinel lymphnode mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations. Gynecol Oncol 2017; 146:405.
https://www.nccn.org/professionals/physician_gls/pdf/cervical.pdf(AccessedonOcto ber 06, 2020).
Rossi EC, Kowalski LD,Scalici J,et al.A comparison of sentinel lymphnode biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. Lancet Oncol 2017; 18:384.
Daraï E, Dubernard G,Bats AS,et al.Sentinel node biopsy for the management of early stage endometrial cancer: long-term results of the SENTI-ENDO study. Gynecol Oncol 2015; 136:54.
Lécuru F,Mathevet P,Querleu D,et al.Bilateral negative sentinel nodes accurately predict absence of lymph node metastasis in early cervical cancer: results of the SENTICOL study. J Clin Oncol 2011; 29:1686.
Lecuru FR, McCormack M,HillemannsP,et al.SENTICOLIII:an international validation study of sentinel node biopsy in early cervical cancer. A GINECO, ENGOT, GCIG and multicenter study. Int J Gynecol Cancer 2019; 29:829.
Schlappe BA,Weaver AL,Ducie JA,et al. Multicenter study comparing oncologic outcomes between two nodal assessment methods in patients with deeply invasive endometrioid endometrial carcinoma: A sentinel lymph node algorithm versus a comprehensive pelvic and paraaortic lymphadenectomy. Gynecol Oncol 2018; 151:235.
Schlappe BA, Weaver AL,McGree ME,et al.Multicenter study comparing oncologic outcomes after lymph node assessment via a sentinel lymph node algorithm versus comprehensive pelvic and paraaortic lymphadenectomy in patients with serous and clear cell endometrial carcinoma. Gynecol Oncol 2020; 156:62.
Kogan L, Matanes E,Wissing M,et al.The added value ofs entinel node mapping in endometrial cancer. Gynecol Oncol 2020; 158:84.
How J, Boldeanu I, Lau S,et al.Unexpected locations of sentinel lymphnodes in endometrial cancer. Gynecol Oncol 2017; 147:18.
Suidan RS, Sun CC, Cantor SB,et al.Three Lymphadenectomy Strategies in Low-Risk Endometrial Carcinoma: A Cost-Effectiveness Analysis. Obstet Gynecol 2018; 132:52.
Backes FJ, Felix AS,Grégoire J,et al.Sentinel lymphnode (SLN) isolated tumorcells (ITCs) in otherwise stage I/II endometrioid endometrial cancer: To treat or not to treat? A bstract, SGO Annual Meeting on Women's Cancer, New Orleans, LA, March 2018.
Frumovitz M, Plante M, Lee PS,et al.Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial. Lancet Oncol 2018; 19:1394.
Zapardiel I, Alvarez J,Barahona M,et al.Utility of Intraoperative Fluorescence Imaging in Gynecologic Surgery: Systematic Review and Consensus Statement. Ann Surg Oncol 2021; 28:3266.
Matsuo K, Machida H, Takiuchi T,et al. Prognosis of women with apparent stage I endometrial cancer who had supracervical hysterectomy. Gynecol Oncol 2017; 145:41.
Creasman WT, Morrow CP, Bundy BN,et al.Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 1987; 60:2035.
Benedetti PaniciP, Basile S,Maneschi F,et al.Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 2008; 100:1707.
ASTEC study group, Kitchener H,Swart AM,et al.Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 2009; 373:125.
Rossi EC, Kowalski LD, Scalici J,et al.A comparison of sentinel lymphnode biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. Lancet Oncol 2017; 18:384.
Holloway RW, Abu-Rustum NR, Backes FJ,et al.Sentinel lymphnode mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations. Gynecol Oncol 2017; 146:405.
Mariani A, Webb MJ, Keeney GL,et al. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol 2000; 182:1506.
Ballester M, Dubernard G, Lécuru F,et al. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO). Lancet Oncol 2011; 12:469.
Cusimano MC,Vicus D,PulmanK,et al. Assessment of Sentinel Lymph Node Biopsy vs Lymphadenectomy for Intermediate- and High-Grade Endometrial Cancer Staging. JAMA Surg 2021; 156:157.
NCCN Clinical Practice Guidelinesin Oncology.Uterine Neoplasms. Available at: http://www.nccnorg/professionals/physician_gls/pdf/uterine.pdf
Zapardiel I, AlvarezJ,Barahona M,et al. Utility of Intraoperative Fluorescence Imaging in Gynecologic Surgery: Systematic Review and Consensus Statement. Ann Surg Oncol 2021; 28:3266.
Tanner EJ, Sinno AK, Stone RL,et al.Factors associated with successful bilateral sentinel lymph node mapping in endometrial cancer. Gynecol Oncol 2015; 138:542.
Cormier B, Rozenholc AT, Gotlieb W,et al.Sentinel lymphnode procedure in endometrial cancer: A systematic review and proposal for standardization of future research. Gynecol Oncol 2015; 138:478.
Nagar H, Wietek N, Goodall RJ,et al.Sentinel node biopsy for diagnosis of lymphnode involvement in endometrial cancer. Cochrane Database Syst Rev 2021; 6:CD013021.
Rossi EC, Jackson A, Ivanova A, Boggess JF. Detection of sentinel nodes for endometrial cancer with robotic assisted fluorescence imaging: cervical versus hysteroscopic injection. Int J Gynecol Cancer 2013; 23:1704.
Martinelli F, Ditto A, Bogani G,et al.Laparoscopic Sentinel Node Mapping in Endometrial Cancer After Hysteroscopic Injection of Indocyanine Green. J Minim Invasive Gynecol 2017; 24:89.
Gezer Ş, Duman Öztürk S, Hekimsoy T,et al. Cervical versus endometrial injection for sentinel lymph node detection in endometrial cancer: a randomized clinical trial. Int J Gynecol Cancer 2020; 30:325.
Ditto A, Casarin J, Pinelli C,et al. Hysteroscopic versus cervical injection for sentinel node detection in endometrial cancer: A multicenter prospective randomised controlled trial from the Multicenter Italian Trials in Ovarian cancer (MITO) study group. Eur J Cancer 2020; 140:1.
Rossi EC, Ivanova A,Boggess JF.Robotically assisted fluorescence-guidedlymphnode mapping with ICG for gynecologic malignancies: a feasibility study. Gynecol Oncol 2012; 124:78.
Barlin JN, Khoury-Collado F, Kim CH,et al. The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes. Gynecol Oncol 2012; 125:531.
Tanner E, Puechl A, Levinson K,et al.Use of an ovel sentinel lymph node mapping algorithm reduces the need for pelvic lymphadenectomy in low-grade endometrial cancer. Gynecol Oncol 2017; 147:535.
Kim CH, Soslow RA, Park KJ,et al. Pathologic ultrastaging improves micrometastasis detection in sentinel lymph nodes during endometrial cancer staging. Int J Gynecol Cancer 2013; 23:964.
Abu-Rustum NR, Yashar CM, Bean S,et al. NCCN Guidelines Insights: Cervical Cancer, Version 1.2020. J Natl Compr Canc Netw 2020; 18:660.
Salvo G, Ramirez PT, Levenback CF,et al.Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer. Gynecol Oncol 2017; 145:96.
Zapardie lI, Alvarez J, Barahona M,et al.Utility of Intraoperative Fluorescence Imaging in Gynecologic Surgery: Systematic Review and Consensus Statement. Ann Surg Oncol 2021; 28:3266.
Tax C, Rovers MM,de Graaf C,et al.The sentinel node procedure in early stage cervical cancer, taking the next step; a diagnostic review. Gynecol Oncol 2015; 139:559.
Frumovitz M, Ramirez PT, Levenback CF. Lymphatic mapping and sentinel lymphnode detection in women with cervical cancer. Gynecol Oncol 2008; 110:S17.
Delomenie M, Bonsang-Kitzis H, Bats AS,et al.The clinical implication of lymphnodes micrometastases and isolated tumor cells in patients with cervical cancer: A systematic review. Eur J Obstet Gynecol Reprod Biol 2019; 241:71.
Kim CH, Soslow RA, Park KJ,et al.Pathologic ultrastaging improves micrometastasis detection in sentinel lymph nodes during endometrial cancer staging. Int J Gynecol Cancer 2013; 23:964.
Cormier B, Diaz JP, Shih K,et al.Establishing a sentinel lymphnode mapping algorithm for the treatment of early cervical cancer. Gynecol Oncol 2011; 122:275.
Selman TJ, Mann C, Zamora J,et al.Diagnostic accuracy of tests for lymphnode status in primary cervical cancer: a systematic review and meta-analysis. CMAJ 2008; 178:855.
Zapardie lI, Alvarez J, Barahona M, et al. Utility of Intraoperative Fluorescence Imaging in Gynecologic Surgery: Systematic Review and Consensus Statement. Ann Surg Oncol 2021; 28:3266.
Levenback CF, Ali S,Coleman RL,et al.Lymphatic mapping and sentinel lymphnode biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study. J Clin Oncol 2012; 30:3786.
